A group of institutional investors has launched a campaign to convince shareholders in AmerisourceBergen (ABC), one of the nation’s largest wholesalers, to support a proposal that would require the company to provide more information on steps taken to manage financial and reputational risks associated with the opioid crisis.

The move was expected after the Securities and Exchange Commission last month rejected efforts by the company to omit the proposals from its upcoming annual shareholder meeting on March 1. Another proposal would require the wholesaler to disclose if its board clawed back compensation from senior executives due to misconduct.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy